GAMMA Investing’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$165K Buy
7,245
+762
+12% +$17.4K 0.01% 1422
2026
Q1
$151K Buy
6,483
+660
+11% +$14.2K 0.01% 1328
2025
Q4
$116K Sell
5,823
-1,503
-21% -$29.4K 0.01% 1473
2025
Q3
$134K Buy
7,326
+180
+3% +$3.51K 0.01% 1266
2025
Q2
$144K Buy
7,146
+2,648
+59% +$50.9K 0.01% 1146
2025
Q1
$81.5K Buy
4,498
+94
+2% +$1.69K 0.01% 1430
2024
Q4
$76.4K Buy
4,404
+285
+7% +$5.47K 0.01% 1312
2024
Q3
$79.5K Buy
4,119
+643
+18% +$11.8K 0.01% 1156
2024
Q2
$57K Buy
3,476
+1,214
+54% +$18.8K 0.01% 1103
2024
Q1
$34.5K Buy
2,262
+1,252
+124% +$19.7K 0.01% 1274
2023
Q4
$16.4K Buy
+1,010
New +$14.1K ﹤0.01% 1625

Other funds holding INVA

GAMMA Investing's INVA Position: Q2 2026 in Review

GAMMA Investing increased its Innoviva (INVA) stake by 12% in Q2 2026, buying an estimated $17.4K and bringing the position to 7,245 shares worth $165K. The position accounts for 0.01% of the portfolio, ranked #1422.

GAMMA Investing first reported a position in INVA in Q4 2023 and has held it in 11 quarters since. 44 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • GAMMA Investing held 7,245 shares of Innoviva worth $165K as of Q2 2026.
  • GAMMA Investing bought 762 Innoviva shares in Q2 2026, an estimated $17.4K.
  • Innoviva made up 0.01% of GAMMA Investing's portfolio in Q2 2026, its #1422 holding.
  • GAMMA Investing first reported a position in Innoviva in Q4 2023 and has held it in 11 quarters since.
  • 44 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.